KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $7.4 million.

  • Pacira BioSciences' Other Working Capital Changes fell 193.94% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.9 million, marking a year-over-year increase of 66.09%. This contributed to the annual value of $7.4 million for FY2024, which is 23.64% down from last year.
  • Latest data reveals that Pacira BioSciences reported Other Working Capital Changes of $7.4 million as of FY2024, which was down 23.64% from $9.6 million recorded in FY2023.
  • Pacira BioSciences' Other Working Capital Changes' 5-year high stood at $9.6 million during FY2023, with a 5-year trough of -$1.6 million in FY2020.
  • Over the past 3 years, Pacira BioSciences' median Other Working Capital Changes value was $7.4 million (recorded in 2024), while the average stood at $6.6 million.
  • Per our database at Business Quant, Pacira BioSciences' Other Working Capital Changes crashed by 141.65% in 2020 and then spiked by 336.34% in 2022.
  • Yearly analysis of 5 years shows Pacira BioSciences' Other Working Capital Changes stood at -$1.6 million in 2020, then rose by 29.42% to -$1.1 million in 2021, then spiked by 336.34% to $2.7 million in 2022, then spiked by 257.13% to $9.6 million in 2023, then decreased by 23.64% to $7.4 million in 2024.